Page last updated: 2024-11-02

orphenadrine and Recrudescence

orphenadrine has been researched along with Recrudescence in 3 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Research Excerpts

ExcerptRelevanceReference
"Tinnitus produced by middle-ear myoclonus is a rare condition."1.32Objective high-frequency tinnitus of middle-ear myoclonus. ( Abdul-Baqi, KJ, 2004)
"A case of recurrent neuroleptic malignant syndrome (NMS) occurring in a 29-year-old man with mild mental handicap and a superadded psychotic disorder is described."1.28Recurrent neuroleptic malignant syndrome in a man with mild mental handicap. ( Bambrick, M; Wilson, D, 1992)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdul-Baqi, KJ1
Pigache, RM1
Bambrick, M1
Wilson, D1

Trials

1 trial available for orphenadrine and Recrudescence

ArticleYear
Effects of placebo, orphenadrine, and rising doses of chlorpromazine, on PAT performance in chronic schizophrenia. A two year longitudinal study.
    Schizophrenia research, 1993, Volume: 10, Issue:1

    Topics: Adult; Attention; Chlorpromazine; Chronic Disease; Dominance, Cerebral; Dose-Response Relationship,

1993

Other Studies

2 other studies available for orphenadrine and Recrudescence

ArticleYear
Objective high-frequency tinnitus of middle-ear myoclonus.
    The Journal of laryngology and otology, 2004, Volume: 118, Issue:3

    Topics: Audiometry, Pure-Tone; Ear Diseases; Ear, Middle; Hearing Loss, Bilateral; Hearing Loss, Sensorineur

2004
Recurrent neuroleptic malignant syndrome in a man with mild mental handicap.
    Journal of intellectual disability research : JIDR, 1992, Volume: 36 ( Pt 4)

    Topics: Adult; Antipsychotic Agents; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combinat

1992